tirzepatide is fda approved says shortage of GLP-1 drug over Zepbound™ (tirzepatide): The Latest FDA-Approved

Tissue Regeneration Studies Investigate the synergistic effects of BPC-157 and TB-500 on tissue healing and regeneration

Slower gut motility means things move less

Both medications present pregnancy risks

Kim, Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity in JAMA Health Forum (2025

Stratus Biolabs operates as a chemical supplier and is not a compounding pharmacy or outsourcing facility under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

The main analysis included all people who started treatment, regardless of any gaps in their therapy, while a sensitivity analysis evaluated outcomes only in people who did not have any gaps in their treatment lasting more than 30 consecutive days